On October 17, 2019 Johnson & Johnson (NYSE: JNJ) reported that its Board of Directors has declared a cash dividend for the fourth quarter of 2019 of $0.95 per share on the company’s common stock (Press release, Johnson & Johnson, OCT 17, 2019, View Source;johnson-announces-quarterly-dividend-for-fourth-quarter-2019-300940675.html [SID1234542345]). The dividend is payable on December 10, 2019 to shareholders of record at the close of business on November 26, 2019. The ex-dividend date is November 25, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!